Diminish attrition risk with iPSC-based safety and toxicity assays
Human iPSC-based tailored assays that provide precise and translational outcomes to confidently advance in the drug discovery pipeline
Accurate safety predictions
for higher clinical success
Our team can perform a set of qualified assays to evaluate drug-induced toxicity in a variety of cell models to uncover potential toxic effects earlier in the process.
Leverage the high predictability and sensitivity of our safety and toxicity assays. Our scientists will optimize and tailor them to your needs to help you make confident decisions earlier in drug discovery.
Study compound-induced effects on blood vessel formationAssay
Evaluate and quantify the levels of clinically relevant biomarkersAssay
Obtain real-time recordings of intracellular calcium fluctuationsAssay
Study drug-induced effects on contractility of cardiac or skeletal muscle cellsAssay
Determine the electrophysiological effects of your therapeutic candidatesAssay
Evaluate endothelial permeability in short and long termAssay
Study drug-induced phenotypic changes in the cell model of your interestAssay
Obtain precise information on compounds' impact on metabolic processes
Enlist the safety
screening experts today
As more and more drug discovery innovators look to capitalize on the unique value only iPSCs can deliver, they look to Ncardia as the uniquely qualified collaborator to join them on their all-important journeys. We’re ready to help make your next step the very best it can be. So let’s start with a conversation – about your vision, goals and expectations for your drug discovery projects.